The Harry Glorikian Show

At The Harry Glorikian Show, I, Harry Glorikian, am your host. In short, I have talks with leaders in the healthcare & life sciences industry about the ongoing data-driven transformation of their industry.

From new ways to diagnose & treat patients, bring down costs & creating new value, all the way to AI algorithms that increase efficiency & accuracy, better data is revolutionizing healthcare.

I turn to doctors, hospital administrators, IT directors, entrepreneurs, & others for help mapping out the changes & their impact on everyone from patients to researchers.

Welcome to the show!

iTunes – Google Play – TuneIN – Stitcher – Spotify

12 Oct: A New Era of Participatory Medicine: Talking with E-Patient Dave, Part 2

A New Era of Participatory Medicine: Talking with E-Patient Dave,…

03 Aug: Jeff Elton On How To Speed Drug Development Using “Real-World Data”

Jeff Elton On How To Speed Drug Development Using Real-World…

20 Jul: Noosheen Hashemi On January’s Personalized Tech For Controlling Blood Sugar

Noosheen Hashemi On January’s Personalized Tech For Controlling Blood Sugar…

05 Jul: Intelligencia’s Vangelis Vergetis on Building a Successful Drug Pipeline

Intelligencia’s Vangelis Vergetis on Building a Successful Drug Pipeline This…

21 Jun: Wendy Chung on the largest study of the Genetics of Autism

Wendy Chung on the largest study of the Genetics of…

At Univfy, Mylene Yao Is Making IVF More Predictable and Affordable Harry Glorikian: Hello. I’m Harry Glorikian, and this is The Harry Glorikian Show, where we explore how technology is changing everything we know about healthcare. Last month on the show, I brought you an interview with David Sable, an investor and a gyn...

View More

Episode 100! Illumina's Phil Febbo on the New Era of Low-Cost Genome Sequencing

Episode 100! Illumina's Phil Febbo on the New Era of Low-Cost Genome Sequencing Welcome to episode 100 of The Harry Glorikian Show! Tune in and read the full transcript of the episode below: Harry Glorikian: Hello. I’m Harry Glorikian, and this is The Harry Glorikian Show, where we explore how technology is changing everything we ...

View More

David Sable is Still Working on Making IVF More Accessible

David Sable is Still Working on Making IVF More Accessible Thanks for tuning in this week to hear David Sable and I talk about industrializing IVF. Here is the full transcript. Final Transcript Harry Glorikian: Hello. I’m Harry Glorikian, and this is The Harry Glorikian Show, where we explore how technology is changing eve...

View More

How H1 Is Networking The Healthcare World, With Ariel Katz

How H1 Is Networking the Healthcare World, with Ariel Katz Final Transcript Harry Glorikian: “LinkedIn meets ZoomInfo meets Zocdoc, but for doctors,” instead of patients. That’s how Ariel Katz describes the information service offered by his company, H1. Katz co-founded H1 in 2017 and he’s still the CEO today. ...

View More

Erwin Seinen Says the Paper Lab Notebook Is Finally Dying with eLabNext

Erwin Seinen Says the Paper Lab Notebook is Finally Dying with eLabNext Full Transcript Harry Glorikian: Hello. I’m Harry Glorikian, and this is The Harry Glorikian Show, where we explore how technology is changing everything we know about healthcare. If you walked into a typical life science research lab at a university ...

View More

How Rune Labs Uses Data to Improve Prospects for Parkinson's Patients

How Rune Labs Uses Data to Improve Prospects for Parkinson's Patients Episode Summary Harry's guest this week, Brian Pepin, says there haven’t really been any advances in the treatment of Parkinson’s Disease in a decade. The standard treatment is still the standard treatment—meaning various drugs to replace dopamine in the brai...

View More

Proscia Pushes Pathology Down the Digital Path

Proscia Pushes Pathology Down the Digital Path In most hospitals, the practice of radiology went digital years ago. Today you'll rarely find a radiologist examining a broken bone or a fluid-filled lung on a sheet of old-fashioned X-ray film. But pathology isn't as computerized. For a variety of cultural, technical, a...

View More

Vibrent Health - the catalyst for mobile Healthcare

Vibrent Health - The Catalyst for Mobile HealthCare Episode Summary We use our smartphones to communicate, shop, navigate, watch videos, take pictures, share our lives on social media, track our exercise, and listen to music and podcasts. So why shouldn’t they also be the main interface to our healthcare experiences? Let's talk...

View More

Life Science Labs Can't Be Automated, But They Can Be Orchestrated

Life Science Labs Can't Be Automated, But They Can Be Orchestrated Episode Summary Wet labs at life science companies look and work the same pretty much everywhere. They're full of incubators, refrigerators, centrifuges, liquid handlers, gene sequencers, DNA and RNA synthesizers, and all sorts of other complex equipment. And a lot of ...

View More

RARE-X WANTS TO BUILD THE DATA INFRASTRUCTURE FOR RARE DISEASE RESEARCH

Rare-X Wants to Build the Data Infrastructure for Rare Disease Research Episode Summary For people with common health problems like diabetes or high blood pressure or high cholesterol, progress in pharmaceuticals has worked wonders and extended lifespans enormously. But there’s another category of people who tend to get overlooked by the drug...

View More

How WHOOP Uses Big Data to Optimize Your Fitness and Health

How WHOOP Uses Big Data to Optimize Your Fitness and Health Episode Summary Most fitness gadgets, like the Fitbit or the Apple Watch, encourage you to get out there every day and “close your rings” or “do your 10,000 steps.” But there’s one activity tracker that’s a little different. The WHOOP isn't designed to tell you when t...

View More

Fixing The Potential Snafu Between Your Physician And Pharmacy

Fixing The potential snafu between your physician and pharmacy Episode Summary When your doctor prescribes a new medicine, there's a pretty good chance that some snafu will crop up before you get it filled. Either your pharmacy doesn't carry it, or your insurance provider won't cover it, or they'll say you need "...

View More

Eric Daimler says Forget Calculus, A Coder needs to focus on Category Theory

Eric Daimler at Conexus says Forget Calculus, Today's Coders Need to Know Category Theory Harry's guest Eric Daimler, a serial software entrepreneur and a former Presidential Innovation Fellow in the Obama Administration, has an interesting argument about math. If you’re a young person today trying to decide which math course you’r...

View More

Lokavant Wants to Help Good Drugs Succeed in Clinical Trials

Lokavant Wants to Help Good Drugs Succeed in Clinical Trials Harry's guest this week is Rohit Nambisan, CEO of Lokavant, a company that helps drug developers get a better picture of how their clinical trials are progressing. He explains the need for the company's services with an interesting analogy: these days, Nambisan points out, you ca...

View More

What Kids Can Learn from Social Robots, with Paolo Pirjanian

What Kids Can Learn from Social Robots, with Paolo Pirjanian This week Harry continues to explore advances in "digital therapeutics" in a conversation with Paolo Pirjanian, the founder and CEO of the robotics company Embodied. They’ve created an 8-pound, 16-inch-high robot called Moxie that’s intended as a kind of substitute therapist ...

View More

Akili built A Video Game to Help Kids with ADHD

Akili built A Video Game to Help Kids with ADHD Can a video game help improve attention skills in kids with ADHD? According to Akili Interactive in Boston, the answer is yes. They’ve created an action game called EndeavorRx that runs on a tablet and uses adaptive AI to help improve focus, attentional control, and multitasking...

View More

Fauna Bio Awakens Medicine to the Mysteries of Hibernation

Fauna Bio Awakens Medicine to the Mysteries of Hibernation Why is hibernation something that bears and squirrels do, but humans don’t? Even more interesting, what’s going on inside a hibernating animal, on a physiological and genetic level, that allows them to survive the winter in a near-comatose state without freezing to death and without...

View More

Finally, a Drug Company Listens to People with Hearing Loss

Finally, a Drug Company Listens to People with Hearing Loss In a day and age when it feels like there are drugs for everything—from restless legs to toenail fungus to stage fright—it's strange the drug industry has almost completely ignored one of our most important organs: our ears. Given that 15 percent of people in the U.S. report a...

View More

Is Your Kid's Infection Bacterial or Viral? MeMed Can Tell

Is Your Kid's Infection Bacterial or Viral? MeMed Can Tell If you’re a parent, you’ve probably had this experience many times: Your young child has a high fever, and maybe a sore throat, but you don’t know exactly what’s wrong. Is it a bacterial infection, in which case an antibiotic might help? Or is it a viral infection, in which...

View More

Netflix Docu-series Star Jacob Glanville Returns To Talk About How The Pandemic Ends —and His New Company

Netflix Docu-series Star Jacob Glanville Returns To Talk About How The Pandemic Ends—and His New Company In March of 2020, as SARS-CoV-2 was first sweeping the globe, Jacob Glanville joined Harry on the podcast to talk about the pandemic and how the kinds of antibody therapies being studied by his company Distributed Bio might help. At the e...

View More

How to see inside your body using CGMs with Maz Brumand from Levels

How to see inside your body using CGMs with Maz Brumand from Levels Until recently, getting a blood glucose measurement required a finger stick. The whole process was so painful and annoying that only diabetics taking insulin bothered to do it regularly. But there’s a new class of devices called continuous glucose monitors, or CGMs, that m...

View More

Getting Value out of Electronic Health Records, with Verana Health

Getting Value out of Electronic Health Records, with Verana Health Healthcare is one of those areas where more data is almost always better. And I talk a lot on the show about how data is helping doctors and patients make smarter decisions. But a lot of the data we’d still like to have is stuck in those arcane Electronic Health Reco...

View More

What Exponential Change Really Means in Healthcare, with Azeem Azhar

What Exponential Change Really Means in Healthcare, with Azeem Azhar As we say here on The Harry Glorikian Show, technology is changing everything about healthcare works—and the reason we keep talking about it month after month is that the changes are coming much faster than they ever did in the past. Each leap in innovation en...

View More

At the Cutting Edge of Computational Precision Medicine, with Rafael Rosengarten

At the Cutting Edge of Computational Precision Medicine, with Rafael Rosengarten Genialis, led by CEO Rafael Rosengarten, is one of the companies working toward a future where there are no more one-size-fits-all drugs—where, instead, every patient gets matched with the best drug for them based on their disease subtype, as measured by gen...

View More

How To Track The Pandemic Using Mobile Data, With Nuria Oliver

How To Track The Pandemic Using Mobile Data, With Nuria Oliver When the coronavirus pandemic swept across the world in early 2020, Spain was one of the countries hardest hit. At the time, Nuria Oliver was a telecommunications engineer working and living in Valencia, one of Spain's 17 autonomous regions. She’d spent years working for comp...

View More

Impact of Artificial Intelligence on the Doctor-Patient relationship

Impact of Artificial Intelligence on the Doctor-Patient relationship We've learned from previous guests that machine learning and other forms of AI are helping to identify better disease treatments, get drugs to market faster, and spot health problems before they get out of hand. But what if they could also help patients find the best doct...

View More

Seqster's Ardy Arianpour on How to smash Health Data Siloes

Seqster's Ardy Arianpour on How to smash Health Data Siloes Your medical records don't make pleasant bedtime reading. And not only are they inscrutable—they're often mutually (and deliberately) incompatible, meaning different hospitals and doctor's offices can't share them across institutional boundaries. Harry's guest this week, Ardy Ar...

View More

Why AI-based computational pathology detects more cancers

Why AI-based computational pathology detects more cancers Chances are you or someone you love has had a biopsy to check for cancer. Doctors got a tissue sample and they sent it into a pathology lab, and at some point you got a result back. If you were lucky, it was negative and there was no cancer. But have you ever wondered exactly what h...

View More

Nanowear's Venk Varadan on the Next-Gen of Wearable Technology

Nanowear's Venk Varadan on the Next-Gen of Wearable Technology Many of us wear wireless, battery-powered medical sensors on our wrists in the form of our smartwatches or fitness trackers. But someday soon, similar sensors may be woven into our very clothing. Harry's guest this week, Nanowear CEO Venk Varadan, explains that his company's mi...

View More

A New Era of Participatory Medicine: Talking with E-Patient Dave, Part 2

A New Era of Participatory Medicine: Talking with E-Patient Dave, Part 2 Today we bring you the second half of Harry's conversation with Dave deBronkart, better known as E-Patient Dave for all the work he’s done to help empower patients to be more involved in their own healthcare. If you missed Part 1 of our interview with Dave, we rec...

View More

E-Patient Dave Says We Still Need Better Access to our Health Data

E-Patient Dave Says We Still Need Better Access to our Health Data The podcast is back with a new name and a new, expanded focus! Harry will soon be publishing his new book The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer. Like his previous book MoneyBall Medicine, it's all about AI and...

View More

How Matthew Might Is Using Computation to Fight Ultra Rare Diseases

How Matthew Might Is Using Computation to Fight Rare Diseases Harry's guest this week is Matthew Might, director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham. Might trained as a computer scientist, but a personal odyssey inspired him to make the switch into precision medicine. Now he uses computati...

View More

Kevin Davies on the CRISPR Revolution and Genome Editing

Kevin Davies on the CRISPR Revolution and Genome Editing This week Harry is joined by Kevin Davies, author of the 2020 book Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing. CRISPR—an acronym for Clustered Regularly Interspaced Short Palindromic Repeats—consists of DNA sequences that evolved to help bacteria...

View More

The Legacy of Stanford’s Biomedical Informatics Program

The Legacy of Stanford’s Biomedical Informatics Program Harry traveled to the San Francisco Bay Area this summer, and while there he interviewed the co-founders of three local data-driven diagnostics and drug discovery startups, all of whom participated in the same graduate program: the Biomedical Informatics Program at Stanford's School...

View More

Jeff Elton On How To Speed Drug Development Using "Real-World Data"

Jeff Elton On How To Speed Drug Development Using Real-World Data Harry's guest this week is Jeff Elton , CEO of a Boston-based startup called Concert AI that's working to bring more "real-world data" and "real-world evidence" into the process of drug development. What's real-world data? It's everything about patients' health that's no...

View More

Noosheen Hashemi On January's Personalized Tech For Controlling Blood Sugar

Noosheen Hashemi On January's Personalized Tech For Controlling Blood Sugar In a companion interview to his June 7 talk with Stanford's Michael Snyder, Harry speaks this week with Noosheen Hashemi, who—with Snyder—co-founded the personalized health startup January.ai in 2017. The company focuses on helping users understand how their bodies...

View More

Intelligencia's Vangelis Vergetis on Building a Successful Drug Pipeline

Intelligencia's Vangelis Vergetis on Building a Successful Drug Pipeline This week Harry sits down with Vangelis Vergetis, the co-founder and co-executive director of Intelligencia.ai, a startup that uses big data and machine learning to help pharmaceutical companies make better decisions throughout the drug development process. Vergetis a...

View More

Wendy Chung on the largest study of the Genetics of Autism

Wendy Chung on the largest study of the Genetics of Autism From her TED talks and her appearances on PBS, geneticist Wendy Chung is known to millions of people as an expert on autism. But thanks to funding from the Simons Foundation, she’s also known to tens of thousands of people with autism and their families as the leader of history�...

View More

Michael Snyder on Using Data to Keep People Healthy

Michael Snyder on Using Data to Keep People Healthy Having helped to bring big data to genomics through the lab techniques he invented, such as RNA-Seq, the Stanford molecular biologist Michael Snyder is focused today on how to use data from devices to increase the human healthspan. Some cars have as many as 400 sensors, Snyder notes. "And...

View More

Geeking Out about Data with Roche’s Angeli Moeller

GeekinG about Data with Roche's AnGeli MoEller Angeli Moeller is a molecular biologist, a neuroscientist, a systems biologist, and a data scientist all rolled into one—which makes her a perfect example of the kind of multidisciplinary executive needed for this new digital health ecosystem defined by big data, AI, and machine learning. She'...

View More

How Tag.bio Makes It Easier to Interrogate Your Data

How Tag.Bio Makes it Easier to Interrogate your data The discoveries medical researchers and drug developers can make are constrained by the kinds of questions they can ask of their data. Unfortunately, when it comes to clinical trial data, or gene expression data, or population health data, it feels like you need a Ph.D. in computer scien...

View More

Richard Fox: Scaling Genome Editing To Drive The Industrial Bio-Economy

Richard Fox: Scaling Genome Editing To Drive The Industrial Bio-Economy This week Harry speaks with Richard Fox, a computational biologist whose work at two life sciences startups, Inscripta and Infinome, is helping to automate and vastly scale up the process of engineering an organism's genome to evoke new functions or uncover important...

View More

Rana el Kaliouby: When Will Machines Understand Human Emotions

Rana el Kaliouby: When Will Machines Understand Human Emotions Computers can interpret the text we type, and they’re getting better at understanding the words we speak. But they’re only starting to understanding the emotions we feel—whether that means anger, amusement, boredom, distraction, or anything else. This week Harry talks with Ra...

View More

Jason Gammack on the Promise of Spatial Biology

Jason Gammack on the Promise of Spatial Biology Episode Summary Rapid and cheap DNA sequencing technology can tell us a lot about which genes a patient is carrying around, but it can't tell us when and where the instructions in those genes get carried out inside cells. Resolve Biosciences—headed by this week's guest, Jason Gammack�...

View More

Auransa - Pek Lum on Using Machine Learning to Match New Drugs with the Right Patients

Auransa's Pek Lum on Using Machine Learning to Match New Drugs with the Right Patients Episode Notes Pek Lum, co-founder, and CEO of Auransa, believes that a lot fewer drugs would fail in Phase 2 clinical trials if they were tested on patients predisposed to respond. The problem is finding the sub-populations of likely high-responde...

View More

Eight Sleep Matteo Franceschetti Says it's time for a Smarter Mattress to improve your health

Eight Sleep Matteo Franceschetti Says it's time for a Smarter Mattress to improve your health Episode Summary This week Harry talks with Matteo Franceschetti, founder and CEO of the Khosla Ventures-backed startup Eight Sleep. The company's smart mattress, called The Pod, is one of the latest (and largest) entries in the burgeoning market fo...

View More

What's more important? Lifespan or Health Span? - Michael Geer

What's more important? Lifespan or Health Span? - Michael Geer Episode Summary Michael Geer is co-founder and CSO (Chief Strategy Officer) of Humanity Health, a London-based startup that's building an iPhone app and subscription service designed to help users slow or reverse their rate of aging. Geer's co-founder Pete Ward has described the...

View More

IntelinAir's AI-driven Image Analysis growing better crops

IntelinAir's Artificial Intelligence-Driven Image Analysis is helping grow better crops Episode Summary This week on MoneyBall Medicine, Harry takes a field trip (literally!) into farming and agriculture. His guests are Al Eisaian co-founder and CEO of crop intelligence IntelinAir, and the company’s director of machine learning, Jennifer ...

View More

Tempus's Joel Dudley on Building a New Infrastructure for Precision Medicine

Tempus's Joel Dudley on Building a New Infrastructure for Precision Medicine Episode Notes What if there were a single company that could connect hospital electronic health record systems to a massive genomic testing and analytics platform? It would be a little like Amazon Web Services (AWS) for healthcare—an enabling platform for anyone ...

View More

Christine Lemke on Evidation's Push to Use Wearables in Healthcare

Christine Lemke on Evidation's Push to Use Wearables in Healthcare Episode Summary This week Harry catches up with Christine Lemke from Evidation Health, a startup in San Mateo, CA, that helps drug developers and other organizations analyze the effectiveness of smart devices and wearables in new types of therapies. Episode Notes ...

View More

Genuity's Thomas Chittenden on Using Genomics to Eradicate Disease

Genuity's Thomas Chittenden on Using Genomics and Statistics to Eradicate Disease Episode Summary This week Thomas Chittenden of Genuity Science tells Harry about the company's work to use the power of causal statistical learning, Bayesian belief networks, and other advanced mathematical techniques to understand those cascading gene interac...

View More

Why Intensive Care Unit Doctors Need a Dashboard-Shane Cooke

Why Intensive Care Unit Doctors Need a Dashboard-Shane Cooke Episode Summary This week Harry interviews the head of Etiometry, a Boston-based startup building visualization systems and decision support software for hospital intensive care units. Shane Cooke says critical care "is an incredibly complex environment where speed matters and inf...

View More

Clinical Trials- Using Digital Twins to Speed Clinical Trials

Charles Fisher on Using Digital Twins to Speed Clinical Trials Episode Summary Charles Fisher is the founder and CEO at Unlearn, a San Francisco company using purpose-built machine learning algorithms that use historical clinical trial data to create "digital twins" of actual participants in randomized controlled drug trials to help predi...

View More

Jeff Booth on Price deflation in Technology and Healthcare

Jeff Booth on Price deflation in healthcare and technology Episode Notes What if all our everyday assumptions about economics are wrong? This week Harry speaks with author and entrepreneur Jeff Booth, who says the most powerful force for change in the future will be deflation: getting more for less. Even the healthcare industr...

View More

How expert in pharmacokinetics, Mark Eller went from AI Sceptic To Supporter

How expert in pharmacokinetics, Mark Eller went from AI Sceptic To Supporter Episode Notes How does an expert in pharmacokinetics, whose only exposure to computers was taking one semester of programming in college to meet a language requirement, become an advocate for the new AI-driven style of drug discovery? This week Harry fi...

View More

Andrew A. Radin With Progress Report on twoXAR

Andrew A. Radin With Progress Report on twoXAR Episode Summary Harry welcomes back Andrew A. Radin, CEO of the drug discovery startup twoXAR, where scientists model pathogenesis computationally to identify potential drug molecules and, ideally shaving years off the drug development process. Episode Notes Harry welcomes back Andr...

View More

Rayid Ghani: How ML and AI Can Both Shape Patient Behavior

Rayid Ghani How AI/ML Can Both Predict and Shape Patient Behavior Episode Notes In this week's show, Harry interviews Rayid Ghani, a computer scientist at Carnegie Mellon University who studies how to use AI and data science to model and influence people's behavior in realms like politics, healthcare, education, and criminal jus...

View More

Oura-CEO Harpreet Rai on a Ring That May Change Covid-19 Detection

Oura's Harpreet Rai on a Ring That May Change Covid-19 Detection Episode Summary This week Harry speaks with Oura CEO Harpreet Rai, who's leading an effort to explore how a wearable sleep-monitoring device—the Oura Ring—can pick up patterns that may help diagnose COVID-19 infections and other problems. The ring is equipped with sensors t...

View More

David Sable on the Revolution in Fertility Treatment

David Sable on the Genetic Revolution in Fertility Treatment Episode Notes David Sable got his start in reproductive medicine in the late 1980s, a time when he says fertility treatments were "very primitive." But by the mid-2000s, he says, new procedures and new insights into the genetics of development had changed everything. His...

View More

Elli Papaemmanuil Explains How Genomics Will Transform Cancer Care

Elli Papaemmanuil Explains How Genomics Will Transform Cancer Care Episode Summary This week Harry speaks with molecular geneticist Elli Papaemmanuil about how newly available genomic data could lead to major improvements in the standard of care for cancer patients, leading to an age of true precision medicine. Episode Notes This ...

View More

Covid-19 - Gregory Bowman on how you can cure Covid-19 from home

Gregory Bowman on How You Can Help Cure the Covid-19 From Home Episode Notes This week Harry interviews Gregory Bowman, an associate professor in the department of biochemistry and molecular biophysics in the School of Medicine at Washington University in St. Louis. Bowman is the current director of Folding@home, a distributed...

View More

Clint Van Marrewijk from SaferMe on COVID-19 Tracing inside Companies

Clint Van Marrewijk from SaferMe on COVID-19 Tracing Inside Companies Episode Notes Harry's guest this week is the founder and CEO of a New Zealand firm, SaferMe, that had developed proximity-based smartphone apps for worker safety. When the coronavirus came along, their apps turned out to be a great way to help companies build their own "...

View More

P-values- what they are and-why they're past-their prime

P-values- what they are and-why they're past-their prime Episode Summary This week Harry quizzes Ulo Palm, the senior vice president of digital sciences at Allergan, about the long and problematic reign of the p-value in statistical analysis, and why it may be time for the biopharma industry to look to more nuanced measures of w...

View More

Data Is Critical to Engineering Antibodies to Block COVID-19

Data Is Critical to Engineering Antibodies to Block COVID-19 Episode Summary Distributed Bio aims to use its computational antibody engineering platform to identify antibodies that protect against SARS and optimize them to block the SARS-CoV2 coronavirus. This week Harry gets a progress update from three key Distributed Bioscienti...

View More

Jacob Glanville fights Covid-19 via Immuno engineering

Jacob Glanville Confronts Coronavirus Through Immuno-engineering - How to find a therapy Episode Summary Harry's guest for this unusually frank and urgent episode is Jacob Glanville, the founding partner, CEO, and president of Distributed Bio. The company is using its skills in computational antibody analysis and optimization to help the drug i...

View More

Ramy Farid on the power of computational drug discovery

Ramy Farid on the Power of Computation in Drug Discovery Episode Summary Harry interviews Ramy Farid, president and CEO of Schrödinger Pharmaceuticals, about the company's success using chemical simulation software to help drug makers zero in on promising drug candidates—and about its recent IPO, which brought in more than twice as much cash...

View More

Illumina's Phil Febbo on Sequencing, Coronavirus and Viral Outbreaks

Illumina's Phil Febbo on Sequencing, Coronavirus and Viral Outbreaks Episode Summary As the Wuhan coronavirus outbreak spreads in Asia, Harry speaks with Phil Febbo, the chief medical officer of Illumina, one of the world's largest makers of equipment for high-throughput DNA sequencing. Febbo highlights sequencing's ...

View More

Why We Need To Revolutionize IVF Through Deep Learning

Why We Need To Revolutionize IVF Through Deep Learning Episode Summary Daniella Gilboa is an embryologist in Israel working to bring the power of AI and machine learning to the embryo selection phase of IVF treatment. She explains how her new startup aims to automate this error-ridden process, raising efficiency and lowering the overall cost ...

View More

Tom Davenport on the Analytics Gap in Healthcare

Tom Davenport on the Analytics Gap in Healthcare Episode Summary Harry's guest this week is Tom Davenport, who argues that the healthcare industry is way behind in its use of big-data analytics software to make smarter decisions about business and patient care. "This is a period of lots of opportunities to use new technologies to change healt...

View More

Milind Kamkolkar Seeing the Forest and the Trees simultaneously at Cellarity

Milind Kamkolkar Seeing the Forest and the Trees simultaneously at Cellarity Episode Summary Harry welcomes Milind Kamkolkar back to the program. The former Sanofi exec is now the chief data and digital officer at Cellarity, a Flagship Pioneering-backed therapeutics startup working to model cell behavior computationally in order to identify n...

View More

Alan Copperman on How Data is Transforming Reproductive Medicine

Alan Copperman on How Data is Transforming Reproductive Medicine EPISODE SUMMARY This week Harry welcomes a guest who could be considered a "poster child" for the movement to incorporate more data into clinical practice: Dr. Alan Copperman, a New York-based specialist in reproductive medicine. He says the data generated by genetic screening...

View More

Gini Deshpande of Numedii on Augmented Intelligence for Drug Discovery

Gini Deshpande of Numedi on Augmented Intelligence for Drug Discovery EPISODE SUMMARY This week Harry talks with Gini Deshpande, the co-founder and CEO of San Mateo, CA-based NuMedii, a company making judicious use of big data and AI to speed up drug discovery. EPISODE NOTES Gini Desphande says she likes to think of "AI" as augmen...

View More

Chris Boone of Pfizer on being a Data Hippie

Chris Boone of Pfizer on being a data hippie EPISODE SUMMARY This week Harry talks with Chris Boone, a leader of Pfizer's effort to use new types of real-world data on patients—from insurance claims to lab tests to molecular profiles to data from wearable health sensor—to speed up drug discovery, development, and testing. EPISODE N...

View More

Kevin Tabb of Beth Israel Lahey Health on How to Get Ahead of Change in Healthcare

Kevin Tabb on Beth Israel Lahey Health on how to get ahead of changes in healthcare EPISODE SUMMARY Harry talks with the CEO and president of Beth Israel Lahey Health, the product of Lahey Health's merger this spring with Beth Israel Deaconess Medical Center and several other hospitals in the Boston region. How does Dr. Tabb manage change ins...

View More

Rhoda Au on Digital Biomarkers and Precision Brain Health

Rhoda Au on digital biomarkers and Precision Brain health EPISODE SUMMARY: Harry speaks with Boston University’s Rhoda Au, who believes that algorithms parsing new kinds of digital data about individual patients could find warning signs of diseases like dementia while they’re still preventable—leading to a new era in which precision medic...

View More

Kathryn Teng on Unlocking the Puzzle of Population Health

Kathryn Teng on Unlocking the puzzle of population EPISODE SUMMARY Harry has a heart-to-heart conversation with Dr. Kathryn Teng, who’s working to use data to implement an access- and experience-based population health model at MetroHealth, the public health system for Cuyahoga County, Ohio. SHOW NOTES Kathryn Teng, MD, is divis...

View More

Alán Aspuru-Guzik and the Revolution in Molecular Design

Alán Aspuru-Guzik and the Revolution in Molecular Design EPISODE SUMMARY Harry gets an update on the merger of AI, robotics, and high-throughput chemistry in the new "self-driving laboratory" from University of Toronto theoretical chemist Alán Aspuru-Guzik. SHOW NOTES Many of the processes carried out in traditional chemistry la...

View More

Jennifer Carter and the Power of Individualized Cancer Care

Jennifer Carter and the Power of Individualised Cancer Care EPISODE SUMMARY This week Harry learns about the power of individualized molecular diagnostics for cancer patients from N-of-One founder Jennifer Levin Carter. SHOW NOTES Dr. Jennifer Carter says it was watching friends and family members stricken with cancer struggle nav...

View More

Mark Boguski on Diagnostic Management Teams in Medicine

Mark Boguski on Diagnostic Management Teams in medicine Episode Summary: In this week's show: Dr. Mark Boguski argues that diagnostic management teams consisting of physicians from diverse specialties, including genetics and genomics, can integrate data from different specialties and improve patient care. It may take doctors some time to ada...

View More

Sandy Aronson Talks Implementation Of AI Tools For Providers

AI World Series - Part 1 - Sandy Aronson - Partners Healthcare talks Implementation of AI tools for Providers Episode Summary: Harry's guest Sandy Aronson argues that AI and apps are not the solution for better healthcaree; more effective care workflows *enabled* by AI and apps are the solution. Aronson is the executive director of information ...

View More

Geisinger's Aalpen Patel On Using AI Technology To Reduce Diagnosis Time

Geisinger's Aalpen Patel on Using AI to Reduce Time to Diagnosis Episode Summary: What if we could use machine learning to train software to read CT scans of patients with intracranial hemorrhaging? Time to diagnosis could be doubled, potentially saving lives. This week Harry discusses such questions with Dr. Aalpen Patel, a physician-engineer who...

View More

Massimo Buscema On Artificial Intelligence And Its Application To Health

Massimo Buscema On Artificial Intelligence And Its Application To Health Episode Summary: Harry's guest in this episode is Massimo Buscema, director of the Semeion Research Center in Rome, Italy, and a full professor at the University of Colorado at Denver. Buscema researches and consults internationally on the theory and applications of AI, arti...

View More

Barrett Rollins The DNA driven Transformation of Oncology

Barrett Rollins: The DNA driven Transformation of Oncologist Episode Summary: Harry's guest for this episode is Dr. Barrett Rollins, the chief scientific officer and faculty dean for academic affairs at Boston's Dana Farber Cancer Institute and the Linde Family Professor of Medicine at Harvard Medical School. Harry and Dr. Rollins dig into how ...

View More

Joel Dudley and What Happens When You Let Data Drive Discovery

Joel Dudley and what happen when you let data and not hypotheses drive discovery Episode Summary: Harry's guest this week is Dr. Joel Dudley from the Icahn School of Medicine at Mount Sinai, where he serves as executive vice president of precision health, associate professor of genetics and genomic sciences, and founding director of the Ins...

View More

How will AI/ML Driven Image Analytics change the future of Neuroimaging?

How will AI/ML-Driven Image Analytics change the future of Neuroimaging Episode Summary: Harry talks with Wim Van Hecke, the founder and CEO of Icometrix—builder of a cloud-based AI platform for analyzing brain MRI and CT scans—to find out how the startup's FDA-cleared technology is changing the way radiologists and other physicians int...

View More

Dr. Robert Green on the Impact of Individual Genomic Data

DR. ROBERT GREEN ON THE IMPACT OF INDIVIDUAL GENOMIC DATA Episode Summary: Harry's guest this week, Dr. Robert Green, is a professor of medicine and genetics at Harvard Medical School and director of the Genomes To People research program at Brigham & Women's Hospital and the Broad Institute of Harvard and MIT. They dig into the individual ...

View More

Sharon Terry on Changes in Drug Discovery, Diagnostics

Sharon Terry on Changes in Drug Discovery, Diagnostics, and the Treatment of Patients Episode Summary: Harry talks with Sharon Terry, president and CEO of Genetic Alliance, about the way drug discovery, diagnostics , and the treatment of patience are changing. Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to ...

View More

Fabien Beckers on AI and the future of medical imaging

Fabien Beckers on AI and the future of medical imaging Episode Summary: Today's radiologists face a deluge of data, and their work can be tedious and error-prone. But should humans even act as radiologists? It's becoming clear that computers and humans working together are better than either alone. Harry's guest this week is Fabien Beck...

View More

MoneyBall Medicine Podcast - AI Applications Summit Special Series (6 Episodes)

MoneyBall Medicine Podcast - AI Applications Summit Special Series (6 Episodes) Welcome to this special series of the Moneyball Medicine Podcast focused on Artificial Intelligence, Machine Learning and Analytics applied to Drug Discovery and Development. This special series was recorded as part of the AI Applications Summit produced by Corey Lane ...

View More

Leapfrog CEO Leah Binder: Price & Quality Transparency helps patients

Leapfrog CEO Leah Binder: Price & Quality Transparency helps patients EPISODE SUMMARY Leapfrog Group president and CEO Leah Binder talks with Harry about data transparency and how it helps inform healthcare decisions by putting the right information in the hands of patients and employers. Please rate and review The Harry Glorikian Show o...

View More

How EHR systems are transformed by Artificial Intelligence

Artificial Intelligence And How It's Transforming EHR Systems Harry's guest John Glaser, senior vice president of Population Health at Cerner, speculates on how business models in healthcare are changing and how artificial intelligence and EHR systems will work together in the future. Please rate and review The Harry Glorikian S...

View More

Dekel Gelbman and How ML Is Changing Rare Disease Diagnosis

Dekel Gelbman and How Machine Learning is Changing Rare Disease Diagnosis EPISODE SUMMARY Harry's guest is Dekel Gelbman, founding CEO of FDNA. The company uses a combination of computer vision, deep learning, and other artificial intelligence techniques to improve and accelerate diagnostics and therapeutics for children with rare dise...

View More

Jason Bhan and How AI Is Enabling Early Disease Detection

Jason BHAn and How AI and Machine learning are enabling early disease detection Episode Summary Jason Bhan, co-founder and chief medical officer of Prognos Health, joins Harry to talk about how machine learning is being used to dig into multi-sourced clinical diagnostic data to improve health by predicting disease early. Please rat...

View More

Niven Narain And How AI And Machine Learning Are Changing Drug Discovery

Niven Narain and how AI and Machine Learning Are Changing Drug Discovery EPISODE SUMMARY Harry interviews Niven Narain, the co-founder, president and CEO of Berg, a Boston-based biopharma company driving the next generation of drugs and diagnostics by combining patient-driven biology and AI to unravel actionable disease insight. Narain ha...

View More

MoneyBall Medicine: Glenn Steele and How Analytics is Changing Healthcare

MoneyBall Medicine: Glenn Steele and How Analytics is Changing Healthcare EPISODE SUMMARY Host Harry Glorikian talks with Dr. Glenn Steele, chairman of G. Steele Health Solutions, which helps healthcare organizations improve quality, and vice chairman of the Health Transformation Alliance, a cooperative of self-insured employers. Dr. S...

View More

The Harry Glorikian Show

subscribe

Popular Episodes

Recent Episodes